Global Injectable Packaging Leader Maintains Annual Outlook Despite CEO Transition Announcement

West Pharmaceutical Services, Inc. (WST) announced on March 9, 2026, that Eric M. Green plans to step down as President, Chief Executive Officer and Chairman of the Board once his successor is appointed. The Board has engaged an external global executive search firm to begin the CEO succession process, targeting a handover in the second half of 2026, and has reaffirmed the 2026 financial guidance first issued on February 12.

In January at Pharmapack 2026 in Paris, the company expanded its biopharmaceutical and vaccine syringe portfolio by launching its new Synchrony S1 prefillable syringe system as a commercial product. At the same time, it released fourth-quarter 2025 results and forecast mid-single-digit revenue growth for 2026, driven by expected demand for delivery devices tied to GLP-1 obesity treatments.

Headquartered in Exton, Pennsylvania, West Pharmaceutical Services is an S&P 500 company specializing in parenteral packaging and delivery systems—rubber stoppers and seals, prefillable syringes and self-injection devices—supplied to global pharmaceutical firms. The company is recognized for providing essential infrastructure to the biopharmaceutical, generic drug and medical device industries through its high-value disposable components and strict regulatory compliance.